Bangalore has emerged as one of India’s fastest-growing biotechnology hubs, attracting startups, research labs, and global healthcare innovators. From pharmaceutical research and genetic engineering to bioinformatics and medical technology, biotech companies in Bangalore are transforming the future of healthcare and life sciences. The city offers a strong ecosystem of skilled professionals, advanced research centers, and government support, making it a preferred destination for biotech businesses and investors alike.
In this article, we will explore some of the top biotech companies in Bangalore, their services, innovations, and how they are contributing to the rapid growth of India’s biotechnology industry. Whether you are a job seeker, investor, student, or entrepreneur, this guide will help you discover the leading biotech firms shaping the future of science and healthcare.
How We Selected These Biotech Companies
These biotech companies have been chosen based on clear and practical guidelines to ensure that the list is reliable and valuable. Here are the factors, followed by a brief, simple description of why they are important.
- R&D strength: We examined the business’s research and development investment, patents, and scientific collaborations. Good R&D reveals that the company is capable of innovation and new therapies or new technologies.
- Regulatory approvals: We verified the approvals of the major agencies (such as US FDA, EMA) and the successful clinical trials. When the product is safe and ready for the market, it is marked by a regulatory win.
- Revenue or funding: We have taken into account recent revenue and funding rounds. Stable finances indicate health and scalability of products or continued research.
- Product pipeline: We evaluated the scope and development phase of the products in development. It is a diverse and advanced pipeline that will give the company multiple growth and impact opportunities.
- The team’s talent and employee strength:The number of team members, leadership and specialist hires were reviewed. The key to making science into commercial products is a skilled team.
- Global presence: Ininternational operations, partnerships and market reach were studied. A global footprint implies a wider reach, regulatory experience and commercialness.
- Collaborations and partnerships: Alliances were observed with universities, pharma companies and research institutes. Partnerships accelerate development and boost credibility.
- The relevance of the market and the unmet need: We examined the company’s ability to fill in medical or scientific gaps. High impact problems have the highest probability of having products that will impact patient and industry.
List of Top 15 Biotech Companies in Bangalore in 2026
1. Biocon
- Founded: 1978
- HQ: Biocon House, Semicon Park, Electronics City, Phase – II, Hosur Road, Bengaluru 560100, Karnataka, India
- founder: Kiran Mazumdar-Shaw
- Website: https://www.biocon.com/
Biocon is one of India’s top biopharmaceutical companies specializing in biotechnology-based products and services in the field of global healthcare. It designs and provides medicines, in both generic and novel biologics, biosimilars and research services. The firm has established a solid position within the affordable, good quality therapy of chronic and complex diseases. It works throughout the world and supplies markets in other countries and India.
Biocon is particularly renowned for their science-based efforts to bring sophisticated medicines to the masses. It has developed from a start-up company to a multinational biotech over the years. It serves clients in the pharmaceutical and biotech sectors in a variety of capacities, including drug development, manufacturing, and research support. It’s one of the leading biotechnology companies in India.
Speciality:
- Biopharmaceuticals.
- Biosimilars.
- Novel biologics.
- Innovation products: generic APIs and formulations.
- Research and development services.
Key services:
- Product development and commercialization of biotechnology products.
- Active pharmaceutical ingredients (APIs) of generic drugs.
- Biosimilar medicines.
- New products—biologics and branded.
- Seamless discovery, development and manufacturing services.
2. Syngene International
- Founded Year: 1993
- Headquarters: Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Bommasandra-Jigani Link Road, Bangalore 560 099, India
- Founder Name: Kiran Mazumdar-Shaw
- Website: www.syngeneintl.com
Syngene International Limited is a global Contract Research Development & Manufacturing (CRDMO) company that provides services to the Pharmaceutical, Biotechnology, Nutrition, Animal Health, Consumer Goods and Specialty Chemical industries. The company has its headquarters in Bangalore, India, with state-of-the-art facilities in three cities comprising 2.5 million sq. ft. – Bangalore, Hyderabad and Mangalore. Highly qualified scientists staff the company, driving its operations, with a total of 5,641 of these.
The company’s services cover all key therapeutic areas and modalities. Syngene went public in 2015 with an IPO on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). It has 360 active clients across the world, including in the United States, Ireland and India, and maintains offices in these countries.
Speciality
- Contract Research Organization
- Contract Development & Manufacturing
- From the discovery of a drug to the commercial production of that drug.
- Small & large molecule manufacturing.
Key Services
- Discovery Services
- Also, Development Services
- Manufacturing Services (cGMP compliant facilities)
- Dedicated R&D Centres
- The manufacturing of a drug substance & drug product
- Effective clinical supply & registration batches.
- Commercial manufacturing volumes
3. Strand Life Sciences
- Founded year: 2000
- Headquarters (HQ): Bengaluru (Bangalore), Karnataka, India
- Founder(s): Vijay Chandru, Ramesh Hariharan, Swami Manohar, and V. Vinay
- Website: https://www.strandls.com
Strand Life Sciences is a life sciences and Bioinformatics start-up from the Indian Institute of Science in India. The company develops software applications and analytics tools for the interpretation of large‑scale genomic and “omics” data, particularly next generation sequencing (NGS) data. It runs genomics laboratories approved by CAP, and provides oncology, germline cancer and rare diseases clinical grade testing.
Strand develops proprietary in‑silico platforms including Strand NGS, StrandOmics and StrandIris for automated clinical reporting and variant interpretation. Healthcare, pharma and research institutions around the world rely on its solutions to speed up the drug discovery process and individual treatment. Strand integrates laboratory assays, bioinformatics and clinical-research experience into a single integrated model. In total, the company will become a top “omics‑enabling” partner for all aspects of the development of precision medicine worldwide.
Speciality
- Genomics and bioinformatics
- Precision and personalised medicine
- Clinical‑grade NGS interpretation
- Computational tools and software for omics data in silico
- CAP‑accredited genomics lab services
Key services
- Analyses of NGS data and clinical reporting
- Variant curation and reporting for somatic and germline variation.
- Liquid‑biopsy and oncology‑oriented diagnostic tests
- The development of bioinformatics software and platforms.
- Data curation of single-cell and spatial transcriptomics data.
- genomic data‑mining and biomarker discovery for pharma has emerged as one of the key areas of focus.
- The molecular diagnostics and clinical research provide support in the lab.
4. MedGenome
- Founded year: 2013
- HQ: Bangalore (Electronic City Phasee-1), Karnataka, India
- Founder: Sam Santhosh
- Website: medgenome.com
MedGenome Labs is India’s leader in genetic diagnostic testing in South Asia. It has the largest CAP-certified lab in South East Asia, located in its Genetic Reference Lab (GRL), Bangalore, with more than 1300 genetic tests available.
The company provides AI-powered and validated genetic testing solutions to clinicians for rare inherited disorders, reproductive genetics, cancer and more. For pharma and biotech companies, MedGenome’s genomics solutions speed up the identification of biomarkers. Sam Santhosh, the founder, was earlier in a software company and now works in gene sequencing.
Speciality
- Research and diagnostics with the aid of genomics.
- Genetic diagnostic testing
- Next-generation sequencing
- Genetic tests powered by AI.
- Multiomics & bioinformatics
Key services
- Whole Genome Sequencing
- Exome Sequencing
- Metagenomic Sequencing
- Blended Genome-Exome Sequencing
- Multiomics & Bioinformatics Services
- Genetic testing in oncology, neurology, cardiology and rare diseases.
5. Anthem Biosciences
- Founded year: 2006
- HQ: No 49, Canara Bank Road, Hosur Rd, Electronics City Phase 1, Bommasandra Industrial Area, Bengaluru (Bangalore), India
- Founder:: Ajay Bhardwaj
- Website: https://anthembio.com
Anthem Biosciences is a Bangalore-based Contract Research and Innovation Service Provider (CRISP) and Contract Research, Development & Manufacturing Organization (CRDMO) to speed up drug discovery and development, serving virtual, small to midsize biotech companies, traditional pharmaceutical and biopharmaceutical companies across the globe.
Based in Electronics City, Bangalore, Anthem has over 500 researchers and has executed over 500 projects for 400+ global clients. The company has an end-to-end capability from early preclinical investigative research through large-scale GMP manufacturing. The 2025 revenue of Anthem was reported as INR 1,845 crore, and the FY25 figure was listed.
Speciality
- Discovery-to-manufacturing CRDMO
- Drug discovery & development
- Organic synthesis & process development.
- Analytical chemistry & regulatory compliance.
Key services
- Organic synthesis
- Process development
- Analytical chemistry
- Study and development of assays and discovery biology (molecular biology)
- DMPK (Drug Metabolism & Pharmacokinetics)
- Toxicology & in vivo pharmacology
- Microbiology
- Regulatory compliance
- GMP manufacturing
6. String Bio
- Founded year 2013
- HQ: Bengaluru, Karnataka, India
- Founders: Ezhil Subbian, Vinod Kumar
- Website: stringbio.com
String Bio is an industrial biotechnology company that makes sustainable raw materials for animal nutrition, agriculture, human nutrition and personal care by harnessing synthetic biology, fermentation technology, chemistry and process engineering. String Bio’s patented gas fermentation platform, SIMP (String Integrated Methane Platform), utilises engineered microbes to convert methane and other greenhouse gases (CO₂, etc.) from industrial waste to high-value proteins, bio-stimulants, crop nutrition molecules and other ingredients without using conventional agriculture or land-intensive supply chains.
By turning waste gases into valuable products, String Bio’s technology creates carbon-neutral or usually carbon-negative materials and cost-competitive and traceable alternatives that bring us closer to climate security by reducing the pressures on land and water resources.
Speciality
- Industrial biotechnology
- Methane-to-value products
- Synthetic biology
- Fermentation technology
Key services
- Animal nutrition ingredients
- Sustainable bio-based products
- Fermentation-based biomanufacturing
- Process development & Scale-up
7. Bugworks Research
- Founded year: 2014.
- HQ: Centre for Cellular & Molecular Platforms, National Centre for Biological Sciences,
- TIFR GKVK Campus, Bellary Road, Bangalore 560 065,
- Founders: Dr. Anand Anandkumar, Dr. Santanu Datta, and Dr. V. Balasubramanian.
- Website: https://bugworksresearch.com.
BugWorks Research is a clinical‑stage biopharmaceutical company that develops novel small‑molecule therapeutics to combat antimicrobial resistance and cancer. The company’s research is dedicated to structure-guided medicinal chemistry and proprietary discovery platforms to discover and design first-in-class or best-in-class antibiotics and immuno-oncology agents. For oncology, Bugworks promotes pre‑clinical immuno‑oncology projects centered on cancers with challenging clinical needs, such as hypoxic tumors.
The firm works with partners around the world, such as the Global Antibiotic Research & Development Partnership, and has secured innovation grants like CARB-X support. Bugworks is committed to the goal of making cutting-edge therapies more widely available in both high-income and emerging markets, both through its Bangalore R&D laboratory and overseas subsidiaries.
Speciality
- Discovering new drugs against antimicrobial resistance (AMR).
- Novel small‑molecule antibiotics
- Immuno‑oncology and targeted cancer therapies.
- Structure‑guided medicinal chemistry and proprietary discovery platforms.
Key services
- Discovery and pre‑clinical development of novel antibiotics.
- AMR & Oncology Lead Optimization & Candidate Selection.
- Development and trial execution of selected assets at the clinical stage.
- Partnerships for R&D with hospitals
- global NGOs, and entities with a pharma orientation.
8. Pandorum Technologies
- Founded year:2011.
- HQ: Bangalore Bioinnovation Centre, Helix Biotech Park, Electronics City Phase 1, Bengaluru 560 100.
- Founder: Arun Chandru Bhowmick.
- Website: pandorum.com.
Pandorum Technologies is a Biotechnology Company specialising in Tissue Engineering and Regenerative Medicine. Produces 3D working human tissues for research and therapeutic applications. The firm brings together biology, engineering and clinical know-how to develop cutting-edge therapeutic products. It has platforms for cornea, liver and lung-related applications.
It also delves into the study of “exosome” and “cell-free” therapies for tissue repair and regeneration. The company is backed by the Indian biotech company, such as BIRAC. It sits at the nexus of biofabrication, translational science and clinical innovation. Pandorum’s overall objective is to foster future medical therapies and research via engineered tissues.
Speciality
- Tissue engineering.
- Regenerative medicine.
- 3D functional human tissues.
- Exosome-based therapies.
Key services
- Bio-engineered tissues.
- 3D bioprinting.
- Disease modeling.
- Drug discovery support.
- Toxicology testing.
- Regenerative therapy platforms.
9. Eyestem Research
- founded year: 2015–2017
- HQ: Centre for Cellular and Molecular Platforms (C-CAMP), NCBS-TIFR, GKVK Post, Bellary Road, Bengaluru, Karnataka 560065
- founder: Dr Jogin Desai
- website: eyestem.com
Eyestem Research is an India‑based biotech developing scalable cell‑replacement therapies with a focus on retinal diseases. The company is incubated at the Centre for Cellular and Molecular Platforms in Bangalore and uses iPSC technology for developing therapeutics. The main program at Eyestem is called Eyecyte‑RPE, which treats damaged retinal pigment epithelium cells and treats geographic atrophy, as well as other degenerative retinal conditions.
The team features four founders who have experience in drug development and in regenerative medicine, as well as researchers who were early drivers for the field of science. Eyestem has proceeded with programs from the preclinical stage to early clinical evaluation, with a focus on making manufacturable, scalable cell products to bring affordable cell therapies to the market. Eyestem pursues India and international avenues of clinical development and engagement with regulators.
Speciality
- iPSC‑based cell therapy
- Translation from preclinical to clinical trials.
- Target scalable, manufacturable cell-replacement product.
Key Services.
- Development of cell therapy products
- Preclinical research
- GMP‑compatible process development.
- Execution of clinical trials
- Regulatory submission of cell therapies for the eye.
10. Zumutor Biologics
- Founded year: 2015
- HQ: CIC Cambridge Campus,1 Broadway, Cambridge, MA 02142
- Founder: Kavitha Iyer Rodrigues
- Website: zumutor.com
Zumutor Biologics is a targeted NK cell therapeutic company in the field of immuno-oncology. It creates first-in-class the therapeutic antibodies with its proprietary human antibody platform called INABLR®. The company works on modulating innate immunity and the tumour microenvironment to fight cancer. Has several antibody programs in its clinical-stage pipeline, including ZM008.
It has research and development facilities in Bangalore, and its principal headquarters are in Cambridge/Boston, USA. The company says it is a “preeminent immunotherapeutics company in the field. In addition, it has progressed to clinical trials with its lead asset. Overall, Zumutor is an antibody engineering and cancer immunotherapy research company.
Speciality:
- Immuno-oncology
- NK therapy can be customized for each patient to attack specific disease-causing cells.
- Antibody engineering
- Tumor microenvironment modulation
Key services:
- Therapeutic antibody development
- Research in the field of cancer immunotherapy using NK cells.
- Developing human antibody library/platforms.
- Oncology pipeline development in the clinical stage
Quick Comparison: Biotech Companies In Bangalore At a Glance
Why Bangalore Attracts Biotech Companies?
Biotech startups are drawn to Bangalore due to its robust science infrastructure, pool of skilled talent, supportive startups and industry networks, and the all-in-one city advantage.
- Talent and ideas flow from the top research centres and universities. Scientists at big institutions such as IISc and specialized labs create useful research and scientists. Companies can build upon the useful research and scientists created at the big institutions, such as IISc and specialized labs.
- Highly trained manpower and talent. Engineers, biologists, data scientists, and seasoned industry veterans reside here, allowing businesses to recruit the perfect blend without waiting around.
- Reduced startup cost through incubators, biotech parks, or shared labs. Acquiring lab space, equipment, and guidance, like at the Bangalore Bioinnovation Centre and biotechnology parks, can help small teams turn into companies more quickly.
- Excellent start-up and investor environment. The surroundings in Bangalore are conducive to startups more broadly (tech and life-science), which leads to an abundance of mentors, investors, and partners with the experience of supporting companies in scaling up.
- Excellent linkage and facilities. It is easy to meet their partners, ship their samples, and collaborate with them globally with its easy access to an international airport, decent connectivity, and other industry hubs.
- Government and policy support. Biotech R&D and commercialization in the region are supported by state and national initiatives, incentives, and programs focused on biotech.
Career Opportunities In Bangalore’s Biotech Sector
The biotech industry in Bangalore is best suited for positions that involve a combination of lab science, data, quality, and compliance; these include research scientists/research associates, bioinformaticians, clinical data analysts, regulatory affairs, and QA/QC specialists.
- Research Associate / Research Scientist: Frequently used in R&D, wet-lab experiments, molecular biology, and discovery. Generally speaking, the entry-level positions are available to new graduates, and more in-depth research positions require experience or higher degrees.
- bio-informatician / bioinformatics scientist, as the fields of genomics and AI-driven biology continue to grow. According to other salary data from Bangalore, the Bangalore salary ranges from ₹2 lakh to ₹15 lakh per year, with an average of around ₹9.5 lakh per year, in a single data snapshot.
- Clinical Data Analyst: Clinical trials-focused roles typically involve data cleaning, reporting, and database management; these positions are typically held by individuals with solid analytical skills, documentation, and life-science background skills.
- Regulatory Affairs Professionals: This is a good midpoint career path that requires knowledge of compliance, filing, product approvals, and quality systems.
- QA/QC Specialist: One of the more suitable entry-level programs for freshers in regulated biotech and pharma environments, particularly where GMP/GLP documentation is a concern.
Biotech Startups In Bangalore to Watch In 2026
These are some of the lesser-known, non-celebrity startups that make up the Bangalore biotech startups to watch in 2026. The reason they’re fascinating is that they’re all tackling a very niche, high-dollar problem in biotech.
1) Azooka Labs
Azooka Labs is one of the few biotech firms developing products that help the genomics industry, as well as protect soil and water. That blend is intriguing because it demonstrates that biotech can be climate-friendly – and high-tech.
- It operates on products that are life science-related and molecular diagnostics.
- It also has a sustainability angle, and it is a big deal for the next wave of biotech.
- It is already established amanufacturer in the field of genomics consumables and is thus well on the way to practical market traction.
2) Mestastop Solutions
Mestastop is one of the most promising startups in the India that focuses on the part of cancer that is so tough to treat: metastasis. Rather than a wide-ranging cancer endeavor, it is focusing on one of the most difficult and significant challenges in cancer.
- It is working on platforms that can identify the risk of early metastasis.
- It has developed proprietary software, such as METAs, METSCAN, and METVivo.
- Uses wet-lab biology and machine learning, making it a modern, data-driven advantage.
3) Cambrian Bioworks
Cambrian Bioworks is special because it is attempting to bring genomics down to size and makeit more affordable and accessible. It’s very important in biotech, since smaller labs often lack access to many research tools for the reasons listed above.
- It is the manufacturer of extraction kits for DNA, RNA, and plasmid DNA.
- It offers products to aid clinical research, drug discovery, and genetic testing.
- The big idea is straightforward yet impactful: Do better biology at a lower cost for more scientists.
Why these names matter
While they are not as well-known as the biggest biotech startups in Bangalore, that’s why you need to keep your eyes out for them! They are solution-focused, practical, and work on real-world problems such as cancer, genomics, sustainable biotech, and more.
- The “green biotech + genomics” story is Azooka Labs.
- The “fight cancer spread early” story is Mestastop.
- Cambrian Bioworks is about the “make genomics affordable” story.
The Future of Biotech Companies In Bangalore
The future of biotech companies in Bangalore is bright and full of hope. Bangalore is also the home of companies such as Biocon and Syngene, and is still gaining popularity due to the blend of talent and expertise of its scientists, its premier universities, and the government that provides all the support. In the past decade, India’s biotech sector has expanded to $165 billion and is projected to reach $300 billion by 2030, a tenfold increase from the $10 billion it was worth in 2014, and the city of Bangalore is at the core of this explosion.
The uniqueness of Bengalore is its synergy in adopting new technologies such as artificial intelligence and machine learning to accelerate drug discovery, develop personalized medicine, and make research more cost-effective and faster. The city is moving towards a sustainable bio-based production, such as laboratory-grown tissues, smart proteins, and products that do not harm the planet anymore, with the new BioE3 policy that the government has introduced. There’s also a need for collaboration, in fact, more than ever, between companies, universities, and research centers, in Bangalore, bringing the best ideas from the lab to life and making it useful for people.
For people at large, it implies more and better healthcare services, new methods of healing, more food security and better crops, and thousands of high-skilled jobs for the young Indians in the biotech boom of Bangalore. Despite the scarcity of resources and regulatory hurdles, Bangalore biotech firms are going beyond mere generic drugs to become the world leaders in innovation, which is something to be really happy about.
Conclusion
With its robust research base, talented workforce, innovative startups, and an ecosystem of global enterprises, Bangalore has emerged as the beating heart of India’s biotech revolution, driving the future of healthcare, genomics, sustainable science, and advanced therapies. Whether you’re a student seeking career opportunities, a job seeker considering the next big company, an investor seeking the next big idea or just someone who wants to know more about the biotech world, something is exciting for you in this city.
Whether an established player like Biocon and Syngene or an emerging power such as Strand Life Sciences, MedGenome, Anthem Biosciences, String Bio or any other, Bangalore has emerged as a place where science and innovation can collaborate to drive solutions to real-world problems and build a healthier, smarter, and more sustainable future.
Read More:
